BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38355870)

  • 1. The role of spine stereotactic radiosurgery for patients with breast cancer metastases.
    Taori S; Adida S; Tang A; Rajan A; Sefcik RK; Burton SA; Flickinger JC; Zinn PO; Gerszten PC
    J Neurooncol; 2024 Apr; 167(2):257-266. PubMed ID: 38355870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic Radiosurgery for Patients with Spinal Metastases from Thyroid Cancer: A 20-Year Experience.
    Taori S; Adida S; Tang A; Rajan A; Sefcik RK; Burton SA; Flickinger JC; Gerszten PC
    World Neurosurg; 2024 May; 185():e653-e661. PubMed ID: 38412942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting survival in 37 consecutive patients undergoing de novo stereotactic radiosurgery for contiguous sites of vertebral body metastasis from renal cell carcinoma.
    Sellin JN; Reichardt W; Bishop AJ; Suki D; Rhines LD; Settle SH; Brown PD; Li J; Rao G; Chang EL; Tatsui CE
    J Neurosurg Spine; 2015 Jan; 22(1):52-9. PubMed ID: 25360530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
    Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
    J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-fraction versus multifraction spinal stereotactic radiosurgery for spinal metastases from renal cell carcinoma: secondary analysis of Phase I/II trials.
    Ghia AJ; Chang EL; Bishop AJ; Pan HY; Boehling NS; Amini B; Allen PK; Li J; Rhines LD; Tannir NM; Tatsui CE; Brown PD; Yang JN
    J Neurosurg Spine; 2016 May; 24(5):829-36. PubMed ID: 26799117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of spine stereotactic radiosurgery for oligometastatic disease.
    Ho JC; Tang C; Deegan BJ; Allen PK; Jonasch E; Amini B; Wang XA; Li J; Tatsui CE; Rhines LD; Brown PD; Ghia AJ
    J Neurosurg Spine; 2016 Aug; 25(2):239-47. PubMed ID: 27035507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spine stereotactic radiosurgery for metastatic sarcoma: patterns of failure and radiation treatment volume considerations.
    Bishop AJ; Tao R; Guadagnolo BA; Allen PK; Rebueno NC; Wang XA; Amini B; Tatsui CE; Rhines LD; Li J; Chang EL; Brown PD; Ghia AJ
    J Neurosurg Spine; 2017 Sep; 27(3):303-311. PubMed ID: 28644075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic radiosurgery for spinal metastases with or without separation surgery.
    Bate BG; Khan NR; Kimball BY; Gabrick K; Weaver J
    J Neurosurg Spine; 2015 Apr; 22(4):409-15. PubMed ID: 25635638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Outcomes After Stereotactic Radiosurgery for Spine Metastases: Radiation Dose-Response for Late Toxicity.
    Ling DC; Flickinger JC; Burton SA; Heron DE; Quinn AE; Bejjani GK; Engh JA; Gerszten PC; Amankulor NM; Vargo JA
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):602-609. PubMed ID: 29678526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spine stereotactic radiosurgery for metastases from hepatobiliary malignancies: patient selection using PRISM scoring.
    Gjyshi O; Boyce-Fappiano D; Pezzi TA; Ludmir EB; Xiao L; Kaseb A; Amini B; Yeboa DN; Bishop AJ; Li J; Rhines LD; Tatsui CE; Briere TM; Ghia AJ
    J Neurooncol; 2020 Jun; 148(2):327-334. PubMed ID: 32358642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of decompression with instrumentation on local failure following spine stereotactic radiosurgery.
    Miller JA; Balagamwala EH; Berriochoa CA; Angelov L; Suh JH; Benzel EC; Mohammadi AM; Emch T; Magnelli A; Godley A; Qi P; Chao ST
    J Neurosurg Spine; 2017 Oct; 27(4):436-443. PubMed ID: 28731393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Definitive single fraction spine stereotactic radiosurgery for metastatic sarcoma: Simultaneous integrated boost is associated with high tumor control and low vertebral fracture risk.
    Shanker MD; Cavazos AP; Li J; Beckham TH; Yeboa DN; Wang C; McAleer MF; Briere TM; Amini B; Tatsui CE; North RY; Alvarez-Breckenridge CA; Cezayirli PC; Rhines LD; Ghia AJ; Bishop AJ
    Radiother Oncol; 2024 Apr; 193():110119. PubMed ID: 38311030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of symptomatic vertebral body compression fractures requiring intervention following single-fraction stereotactic radiosurgery for spinal metastases.
    Virk MS; Han JE; Reiner AS; McLaughlin LA; Sciubba DM; Lis E; Yamada Y; Bilsky M; Laufer I
    Neurosurg Focus; 2017 Jan; 42(1):E8. PubMed ID: 28041324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic Body Radiotherapy (SBRT) for Spinal Metastases: Who Will Benefit the Most from SBRT?
    Park HJ; Kim HJ; Won JH; Lee SC; Chang AR
    Technol Cancer Res Treat; 2015 Apr; 14(2):159-67. PubMed ID: 24502552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local disease control for spinal metastases following "separation surgery" and adjuvant hypofractionated or high-dose single-fraction stereotactic radiosurgery: outcome analysis in 186 patients.
    Laufer I; Iorgulescu JB; Chapman T; Lis E; Shi W; Zhang Z; Cox BW; Yamada Y; Bilsky MH
    J Neurosurg Spine; 2013 Mar; 18(3):207-14. PubMed ID: 23339593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and utility of kyphoplasty prior to spine stereotactic radiosurgery for metastatic tumors: a clinical and dosimetric analysis.
    Barzilai O; DiStefano N; Lis E; Yamada Y; Lovelock DM; Fontanella AN; Bilsky MH; Laufer I
    J Neurosurg Spine; 2018 Jan; 28(1):72-78. PubMed ID: 29087812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic body radiotherapy as a primary treatment for spinal metastasis: a single institution experience.
    Yeung WME
    Ann Palliat Med; 2020 Nov; 9(6):4467-4477. PubMed ID: 33302690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spine Stereotactic Radiosurgery for Patients with Metastatic Thyroid Cancer: Secondary Analysis of Phase I/II Trials.
    Bernstein MB; Chang EL; Amini B; Pan H; Cabanillas M; Wang XA; Allen PK; Rhines LD; Tatsui C; Li J; Brown PD; Ghia AJ
    Thyroid; 2016 Sep; 26(9):1269-75. PubMed ID: 27334245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of cervicothoracic region stereotactic spine radiosurgery on adjacent organs at risk.
    Sharma M; Bennett EE; Rahmathulla G; Chao ST; Koech HK; Gregory SN; Emch T; Magnelli A; Meola A; Suh JH; Angelov L
    Neurosurg Focus; 2017 Jan; 42(1):E14. PubMed ID: 28041323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological characteristics of spine metastases treated with high-dose single-fraction stereotactic radiosurgery.
    Katsoulakis E; Laufer I; Bilsky M; Agaram NP; Lovelock M; Yamada Y
    Neurosurg Focus; 2017 Jan; 42(1):E7. PubMed ID: 28041326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.